HAEHaemonetics Corporation

HAE Stock Price, Valuation & Chart | Haemonetics Corporation

Compare

$102.92+0.97 (+0.95%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Instruments & Supplies HAE intrinsic value HAE calculated fair value vs price

Overview Financials Dividends Ratios

HAE Historical price chart

HAE Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization4.68B

PE Ratio20.54

EPS5.01

Trading Volume750.51K

Today's High/Low104.37/102.43

Dividend Yield0.00

52 Week High/Low109.57/47.32

Shares Outstanding45.45M

HAE Financial Statement

HAE Analyst ratings

HAE Analysis & performance metrics

HAE Company profile

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company…

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated…

HAE Management team

Name

Position

Christopher A. SimonCEO

Chief Executive Officer, President & Director

James C. D'Arecca CPACFO

Chief Financial Officer, Executive Vice President & Financial Officer

Michelle L. Basil Esq., J.D.

Executive Vice President, General Counsel & Secretary

Laurie A. Miller

Senior Vice President & Chief Human Resources Officer

Olga GuyetteCTO

Senior Director of Investor Relations

Roy Galvin

Executive Vice President & Chief Commercial Officer

Farris Maryanne Maunsell

Vice President, Chief Accounting Officer & Principal Accounting Officer

Rajeev Varma

Senior Vice President of Strategy & Corporate Development

Name

Position

Christopher A. SimonCEO

Chief Executive Officer, President & Director

James C. D'Arecca CPACFO

Chief Financial Officer, Executive Vice President & Financial Officer

Michelle L. Basil Esq., J.D.

Executive Vice President, General Counsel & Secretary

Laurie A. Miller

Senior Vice President & Chief Human Resources Officer

Olga GuyetteCTO

Senior Director of Investor Relations

Roy Galvin

Executive Vice President & Chief Commercial Officer

Farris Maryanne Maunsell

Vice President, Chief Accounting Officer & Principal Accounting Officer

Rajeev Varma

Senior Vice President of Strategy & Corporate Development

Management Team

Christopher A. SimonCEO

Chief Executive Officer, President & Director

James C. D'Arecca CPACFO

Chief Financial Officer, Executive Vice President & Financial Officer

Michelle L. Basil Esq., J.D.

Executive Vice President, General Counsel & Secretary

Laurie A. Miller

Senior Vice President & Chief Human Resources Officer

Olga GuyetteCTO

Senior Director of Investor Relations

Roy Galvin

Executive Vice President & Chief Commercial Officer

Farris Maryanne Maunsell

Vice President, Chief Accounting Officer & Principal Accounting Officer

Rajeev Varma

Senior Vice President of Strategy & Corporate Development

Management

Christopher A. SimonCEO

Chief Executive Officer, President & Director

James C. D'Arecca CPACFO

Chief Financial Officer, Executive Vice President & Financial Officer

Michelle L. Basil Esq., J.D.

Executive Vice President, General Counsel & Secretary

Laurie A. Miller

Senior Vice President & Chief Human Resources Officer

Olga GuyetteCTO

Senior Director of Investor Relations

Roy Galvin

Executive Vice President & Chief Commercial Officer

Farris Maryanne Maunsell

Vice President, Chief Accounting Officer & Principal Accounting Officer

Rajeev Varma

Senior Vice President of Strategy & Corporate Development

Total 8 executives

HAE Frequently asked questions

What is Haemonetics Corporation (HAE) Stock Price?

Current stock price of Haemonetics Corporation (HAE) stock is $102.92. The stock price is +0.95% higher in the session. The intraday range can be seen from this page. Volume of Haemonetics Corporation (HAE) stock is 750.51K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Haemonetics Corporation (HAE) stock price going up or down today?

The stock price of Haemonetics Corporation (HAE) can change with earnings, company news, and overall market sentiment. Haemonetics Corporation operates in the Healthcare / Medical - Instruments & Supplies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Haemonetics Corporation stock expensive at its current price?

Whether Haemonetics Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for HAE on this page is 20.54. EPS on this page is 5.01. Compare those figures with peers and growth expectations before deciding if the current Haemonetics Corporation price is justified.

How has the stock price of Haemonetics Corporation (HAE) performed historically?

Historical performance for Haemonetics Corporation (HAE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how HAE reacted to past earnings and market events.

Should I buy Haemonetics Corporation (HAE) stock, at this price?

Buying Haemonetics Corporation (HAE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.